GROUP SEQUENTIAL CLINICAL-TRIALS - A CLASSICAL EVALUATION OF BAYESIAN DECISION-THEORETIC DESIGNS
GROUP SEQUENTIAL CLINICAL-TRIALS - A CLASSICAL EVALUATION OF BAYESIAN DECISION-THEORETIC DESIGNS
复制标题
DOI:
10.2307/2291016
复制
发表时间:
1994-12-01
影响因子:
3.7
通讯作者:
BERRY, DA
中科院分区:
文献类型:
--
作者:
LEWIS, RJ;BERRY, DA
Bayesian decision-theoretic designs for a clinical trial comparing two treatments for a disease with binary outcomes are developed and evaluated. The probability of successful outcome with treatment i is denoted by p(i), i = 1, 2, and prior knowledge regarding each p(i) is assumed to follow a beta distribution. The p(i) are assumed to be independent. To facilitate comparison with frequentist clinical trial designs, we take a hypothesis-testing approach. The null hypothesis is delta > delta(0), and the alternative hypothesis is delta > 0, where delta(0) is the minimum treatment effect sought by the trial and delta = p(2), - p(1) is the true treatment difference. We use a simple terminal loss function reflecting the hypothesis-testing goal of the trial, and the total cost of the trial is the final sample size plus the terminal loss function. The stopping and decision rules that minimize the expectation of the total cost are determined by backward induction. Monte Carlo simulation is used to compare Bayesian and frequentist error rates and mean sample sizes of these Bayesian designs with one-tailed classical group-sequential designs of Pocock and O'Brien-Fleming. As expected, the Bayesian decision-theoretic designs have smaller mean costs than the classical designs. More surprising, when the magnitude of the terminal loss function is chosen to yield frequentist error rates similar to those for classical designs, the mean sample sizes of the Bayesian designs are usually smaller.